Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,629.98
(
0.47%
)
News Focus
News Focus

Replies to post #244342 on Biotech Values

Replies to #244342 on Biotech Values
icon url

DewDiligence

10/28/22 11:09 AM

#244343 RE: jbog #244342

ABBV's slowdown in aesthetic procedures is mainly for dermal fillers and CoolSculpting, according to CEO Rick Gonzalez on today's CC. Dermal fillers and CoolSculpting are more expensive treatments than Botox.